title: Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan.
abstract: An association between specific human leukocyte antigens (HLA) alleles and nasopharyngeal carcinoma (NPC) has been reported for sporadic NPC, but studies of familial NPC are lacking. We evaluated this association with familial NPC in a study of 301 NPC cases and 1010 family and community controls from Taiwan. Class I HLA alleles were characterized using a sequence-based typing protocol. Allele frequencies between case and control groups were compared by chi(2) or exact tests. For alleles associated with NPC, odds ratios (OR) and 95% confidence intervals (CI) were calculated. Similar allelic frequency distribution and HLA associations were found as those previously reported for sporadic NPC: protective effect for HLA-A*1101 and increased risk for HLA-A*0207, HLA-A*3303, HLA-B*3802, and HLA-B*5801. Overall, the magnitude of observed associations was weakest when cases were compared with sibling controls and strongest when compared with unrelated community controls. Evaluating the joint effect of HLA-A*0207 and HLA-B*4601, individuals who were carriers of HLA-A*0207 with or without the presence of HLA-B*4601 had a 1.9-fold (95% CI = 1.0-3.4) and 2.1-fold (95% CI = 0.83-5.3) risk of NPC, respectively. Conversely, carriers of HLA-B*4601 in the absence of HLA-A*0207 had a 50% reduction in NPC risk (95% CI = 0.27-0.93). Comparable findings from our family study and those from previous sporadic studies were found with the notable exception of a lack of positive association between HLA-B*4601 and familial NPC in the absence of HLA-A*0207. This finding requires replication in larger studies.
authors.affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA. yuke@mail.nih.gov
authors.forename: Kelly J
authors.initials: KJ
authors.lastname: Yu
authors.forename: Xiaojiang
authors.initials: X
authors.lastname: Gao
authors.forename: Chien-Jen
authors.initials: CJ
authors.lastname: Chen
authors.forename: Xiaohong Rose
authors.initials: XR
authors.lastname: Yang
authors.forename: Scott R
authors.initials: SR
authors.lastname: Diehl
authors.forename: Alisa
authors.initials: A
authors.lastname: Goldstein
authors.forename: Wan-Lun
authors.initials: WL
authors.lastname: Hsu
authors.forename: Xueying Sharon
authors.initials: XS
authors.lastname: Liang
authors.forename: Darlene
authors.initials: D
authors.lastname: Marti
authors.forename: Mei-Ying
authors.initials: MY
authors.lastname: Liu
authors.forename: Jen-Yang
authors.initials: JY
authors.lastname: Chen
authors.forename: Mary
authors.initials: M
authors.lastname: Carrington
authors.forename: Allan
authors.initials: A
authors.lastname: Hildesheim
mesh_terms: D000483:Alleles; D005260:Female; D020022:Genetic Predisposition to Disease; D015234:HLA-A Antigens / Q000235:genetics*; D015235:HLA-B Antigens / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000235:genetics*; D012307:Risk Factors; D013624:Taiwan
chemical_list: D015234:HLA-A Antigens; D015235:HLA-B Antigens
references.citation: J Virol. 1996 Apr;70(4):2490-6
references.pmid: 8642677
references.citation: Annu Rev Immunol. 1997;15:405-31
references.pmid: 9143694
references.citation: Clin Otolaryngol Allied Sci. 2001 Apr;26(2):82-92
references.pmid: 11309046
references.citation: Nature. 1990 Aug 2;346(6283):470-1
references.pmid: 2377207
references.citation: Cancer Causes Control. 1999 Jun;10(3):201-7
references.pmid: 10454065
references.citation: J Med Virol. 1985 Sep;17(1):47-9
references.pmid: 2995572
references.citation: Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1996 May;29(2):65-79
references.pmid: 10592788
references.citation: J Natl Cancer Inst. 2002 Dec 4;94(23):1780-9
references.pmid: 12464650
references.citation: Ann Acad Med Singap. 1990 Mar;19(2):201-7
references.pmid: 2189340
references.citation: Int J Cancer. 2004 Aug 10;111(1):117-23
references.pmid: 15185352
references.citation: J Virol. 1993 Mar;67(3):1572-8
references.pmid: 7679748
references.citation: Int J Cancer. 1985 Nov 15;36(5):545-7
references.pmid: 4055129
references.citation: Proc Natl Acad Sci U S A. 1980 Oct;77(10):6162-5
references.pmid: 6255477
references.citation: Behav Genet. 1972 Mar;2(1):3-19
references.pmid: 4157472
references.citation: Science. 2008 Nov 7;322(5903):881-8
references.pmid: 18988837
references.citation: Epidemiol Rev. 1993;15(2):466-85
references.pmid: 8174667
references.citation: J Natl Cancer Inst. 1997 Aug 20;89(16):1207-12
references.pmid: 9274915
references.citation: Science. 1993 Apr 2;260(5104):98-100
references.pmid: 7682013
references.citation: Nat Rev Cancer. 2004 Nov;4(11):850-60
references.pmid: 15516958
references.citation: N Engl J Med. 2000 Aug 17;343(7):481-92
references.pmid: 10944566
references.citation: Nat Genet. 2002 Aug;31(4):395-9
references.pmid: 12118254
references.citation: Int J Cancer. 1997 Apr 22;74(2):229-32
references.pmid: 9133461
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):900-5
references.pmid: 15826929
references.citation: Int J Cancer. 1976 Jan 15;17(1):1-7
references.pmid: 175020